Additionally, the overall mutation frequency of NOTCH4 was 2.96% (324/10,953) in the TCGA pan-cancer cohort, with melanoma at 15.61% (69/442) ranking first (Figure 2A). The gene discussed is NOTCH4; the disease is cancer.